ketorolac has been researched along with Ureteral Obstruction in 3 studies
Ketorolac: A pyrrolizine carboxylic acid derivative structurally related to INDOMETHACIN. It is an NSAID and is used principally for its analgesic activity. (From Martindale The Extra Pharmacopoeia, 31st ed)
ketorolac : A racemate comprising equimolar amounts of (R)-(+)- and (S)-(-)-5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid. While only the (S)-(-) enantiomer is a COX1 and COX2 inhibitor, the (R)-(+) enantiomer exhibits potent analgesic activity. A non-steroidal anti-inflammatory drug, ketorolac is mainly used (generally as the tromethamine salt) for its potent analgesic properties in the short-term management of post-operative pain, and in eye drops to relieve the ocular itching associated with seasonal allergic conjunctivitis. It was withdrawn from the market in many countries in 1993 following association with haemorrhage and renal failure.
5-benzoyl-2,3-dihydro-1H-pyrrolizine-1-carboxylic acid : A member of the class of pyrrolizines that is 2,3-dihydro-1H-pyrrolizine which is substituted at positions 1 and 5 by carboxy and benzoyl groups, respectively.
Ureteral Obstruction: Blockage in any part of the URETER causing obstruction of urine flow from the kidney to the URINARY BLADDER. The obstruction may be congenital, acquired, unilateral, bilateral, complete, partial, acute, or chronic. Depending on the degree and duration of the obstruction, clinical features vary greatly such as HYDRONEPHROSIS and obstructive nephropathy.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The parameters considered as prognostic factors were pain relief with ketorolac (K) or ketorolac plus opiate treatment (KO), and stone size (>or= or <6 mm)." | 3.71 | Comparison of stone size and response to analgesic treatment in predicting outcome of patients with renal colic. ( Prina, LD; Rancatore, E; Secic, M; Weber, RE, 2002) |
| "In the patients with renal colic the average resistive index (RI) was significantly greater on the side of the colic after administration of either indomethacin or ketorolac (p<0." | 2.71 | Resistive index in patients with renal colic: differences after medical treatment with indomethacin and ketorolac. ( Bertolotto, M; Calderan, L; Gasparini, C; Pozzi Mucelli, R; Quaia, E, 2003) |
| "Complete ureteral obstruction was obtained using a Fogarty balloon catheter passed retrogradely into the distal ureter and inflated." | 1.27 | Comparative effects of four prostaglandin synthesis inhibitors on the obstructed kidney in the dog. ( Gasparich, JP; Mayo, ME, 1986) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Prina, LD | 1 |
| Rancatore, E | 1 |
| Secic, M | 1 |
| Weber, RE | 1 |
| Bertolotto, M | 1 |
| Quaia, E | 1 |
| Gasparini, C | 1 |
| Calderan, L | 1 |
| Pozzi Mucelli, R | 1 |
| Gasparich, JP | 1 |
| Mayo, ME | 1 |
1 trial available for ketorolac and Ureteral Obstruction
| Article | Year |
|---|---|
Resistive index in patients with renal colic: differences after medical treatment with indomethacin and ketorolac.
Topics: Acute Disease; Anti-Inflammatory Agents, Non-Steroidal; Colic; Humans; Indomethacin; Ketorolac; Kidn | 2003 |
2 other studies available for ketorolac and Ureteral Obstruction
| Article | Year |
|---|---|
Comparison of stone size and response to analgesic treatment in predicting outcome of patients with renal colic.
Topics: Analgesics, Opioid; Anti-Inflammatory Agents, Non-Steroidal; Colic; Emergency Service, Hospital; Fem | 2002 |
Comparative effects of four prostaglandin synthesis inhibitors on the obstructed kidney in the dog.
Topics: Animals; Blood Pressure; Dogs; Female; Ibuprofen; Indomethacin; Ketorolac; Kidney Pelvis; Naproxen; | 1986 |